<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03528122</url>
  </required_header>
  <id_info>
    <org_study_id>63 2/2018</org_study_id>
    <nct_id>NCT03528122</nct_id>
  </id_info>
  <brief_title>Amniotic Membrane for Recurrent Macular Hole</brief_title>
  <official_title>The Safety and Efficacy of Using Amniotic Membrane for Closure of Recurrent Macular Hole</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Macular hole surgery were tried by different surgeons using many techniques with different
      successes but still there were many recurrences. In this study the investigators try to close
      these distinct types including recurrent holes using pre-prepared amniotic membrane.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is an interventional study of using amniotic membrane graft for closure of macular hole
      associated retinal detachment in patient who had a previous failed macular surgery.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">May 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Individuals with recurrent macular hole associated retinal detachment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anatomical restoration of macular hole closure</measure>
    <time_frame>6 months</time_frame>
    <description>Closure of the macular hole</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional restoration after closure of the macular hole</measure>
    <time_frame>6 months</time_frame>
    <description>Improvement of the best corrected visual acuity (BCVA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional restoration after closure of the macular hole</measure>
    <time_frame>6 months</time_frame>
    <description>Any improvement of the waves in the electrophysiological (ERG) study.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Macula Hole</condition>
  <condition>Retinal Detachment</condition>
  <condition>Myopic Macular Degeneration</condition>
  <arm_group>
    <arm_group_label>Recurrent opened macular hole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pars plana vitrectomy with internal limiting membrane peel if not peeled in the first surgery and application of amniotic membrane graft</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Recurrent opened macular hole</intervention_name>
    <description>pars plana vitrectomy + internal limiting membrane peeling + Amniotic membrane graft placement over the hole + intraocular tamponade</description>
    <arm_group_label>Recurrent opened macular hole</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with history of opened macular hole after previous pars plana vitrectomy and
             internal limiting membrane (ILM) peeling for treatment of myopic macular hole were
             included.

          -  Opened holes after 1 month of the surgery.

          -  Myopic macular holes only were included (Refraction of more than _6 D and/or axial
             length of more than 26 mm).

        Exclusion Criteria:

          -  All other causes of macular hole (traumatic and idiopathic)

          -  Patients with diseases that can affect visual outcome (Diabetic retinopathy, choroidal
             neovascularization, age-related macular disease and advanced glaucoma patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Minia UNiversity hospital</name>
      <address>
        <city>Minya</city>
        <state>Minia</state>
        <zip>61111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>April 21, 2018</study_first_submitted>
  <study_first_submitted_qc>May 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2018</study_first_posted>
  <last_update_submitted>February 18, 2020</last_update_submitted>
  <last_update_submitted_qc>February 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Hossam Mohamed Moharram</investigator_full_name>
    <investigator_title>Assistant Professor of Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>amniotic membrane</keyword>
  <keyword>retinal detachment</keyword>
  <keyword>Myopic</keyword>
  <keyword>macular hole</keyword>
  <keyword>internal limiting membrane</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Retinal Detachment</mesh_term>
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

